ALMS · ISSUER CIK 1847367
ALUMIS INC.
Between Jul 31, 2026 and Oct 28, 2026, 7 ALUMIS INC. insiders reported $10.7M of open-market purchases and $1.4M of sales on SEC Form 4. The largest buyer was Akkaraju Srinivas (Director), with $10.7M.
↗7 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 0 of 7 sales were reported under a 10b5-1 plan.
$10.7MInsider buying
$1.4MInsider selling
+$9.3MNet open-market
Sep 9, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 202621:39 | Sep 8, 2026 | ALMS | Director | S · Sell | $10.55 | −96,131 | 2,025,493 | -5% | −$1.0M | ||
| Sep 9, 202621:39 | Sep 8, 2026from Sep 4, 2026 | ALMS | Director | P · Buy | $10.87 | +986,721 | 2,298,783 | +75% | +$10.7M | -64.1% | -34.4% |
| Aug 5, 202618:50 | Aug 3, 2026 | ALMS | Chief Financial Officer | S · Sell | $26.37 | −3,282 | 24,718 | -12% | −$87K | ||
| Aug 5, 202618:46 | Aug 3, 2026 | ALMS | Chief Legal Officer | S · Sell | $26.37 | −1,364 | 9,747 | -12% | −$36K | ||
| Aug 5, 202618:44 | Aug 3, 2026 | ALMS | Chief Business & Strategy Ofcr | S · Sell | $26.37 | −2,692 | 207,746 | -1% | −$71K | ||
| Aug 5, 202618:40 | Aug 3, 2026 | ALMS | Chief Scientific Officer | S · Sell | $26.37 | −2,596 | 30,970 | -8% | −$68K | ||
| Aug 5, 202618:36 | Aug 3, 2026 | ALMS | Chief Medical Officer | S · Sell | $26.37 | −2,447 | 56,892 | -4% | −$65K | ||
| Aug 5, 202618:21 | Aug 3, 2026 | ALMS | Chief Development Officer | S · Sell | $26.37 | −2,572 | 48,533 | -5% | −$68K |